Pharma companies need to limit the presence of nitrosamines in human medicines: EMA EH News Bureau Jul 10, 2020 Patients should generally not be exposed to a lifetime risk of cancer exceeding 1 in 100,000 from nitrosamines in their medicines
Faulty Medical Devices: A Value Chain gone Berserk? EH News Bureau Mar 12, 2019 Prashant K Singh, Director, Coordination and Strategy Development, at the Public Health Foundation of India. expounds on how…
